Engineers Gate Manager’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,269
| Closed | -$35.4K | – | 2319 |
|
|
2024
Q1 | $35.4K | Hold |
22,269
| – | – | ﹤0.01% | 1821 |
|
|
2023
Q4 | $19.1K | Buy |
22,269
+11,240
| +102% | +$9.66K | ﹤0.01% | 1908 |
|
|
2023
Q3 | $11.8K | Buy |
+11,029
| New | +$11.8K | ﹤0.01% | 1724 |
|
|
2022
Q3 | – | Sell |
-27,026
| Closed | -$346K | – | 2177 |
|
|
2022
Q2 | $346K | Sell |
27,026
-13,587
| -33% | -$174K | 0.01% | 1320 |
|
|
2022
Q1 | $619K | Sell |
40,613
-1,597
| -4% | -$24.3K | 0.02% | 945 |
|
|
2021
Q4 | $748K | Buy |
42,210
+12,751
| +43% | +$226K | 0.03% | 778 |
|
|
2021
Q3 | $619K | Sell |
29,459
-29,721
| -50% | -$625K | 0.04% | 754 |
|
|
2021
Q2 | $1.17M | Buy |
59,180
+35,727
| +152% | +$705K | 0.08% | 365 |
|
|
2021
Q1 | $682K | Sell |
23,453
-10,278
| -30% | -$299K | 0.03% | 807 |
|
|
2020
Q4 | $1.02M | Sell |
33,731
-10,561
| -24% | -$320K | 0.04% | 589 |
|
|
2020
Q3 | $705K | Sell |
44,292
-13,214
| -23% | -$210K | 0.03% | 808 |
|
|
2020
Q2 | $1.14M | Buy |
57,506
+13,353
| +30% | +$264K | 0.06% | 546 |
|
|
2020
Q1 | $544K | Buy |
+44,153
| New | +$544K | 0.04% | 721 |
|